Publication date: Jun 01, 2025 Notwithstanding the indefatigable endeavors to develop effective anti-mycobacterial therapies, mycobacterial infections still present a tough problem for medicine today. The problem is further complicated by ... Read more

Publication date: May 02, 2025 Antimicrobial resistance poses a grave threat to global public health. Although new antibiotics are urgently needed, most share resistance mechanisms with existing drugs, thereby necessitating ... Read more

Publication date: May 06, 2025 Mycobacterium abscessus is a rapidly growing nontuberculous Mycobacterium causing severe pulmonary infections, especially in immunocompromised individuals and patients with underlying lung conditions like cystic fibrosis ... Read more

Publication date: Apr 21, 2025 Deferring ART until a CD4 count below cells/mm or other clinical indication in people with HIV (PWH) carries an increased risk of severe bacterial infections ... Read more

Publication date: May 09, 2025 Non-tuberculous mycobacterial infections are rising as complications of bone marrow transplantation with lung disease being the most common clinical presentation. The identification and management of ... Read more

Publication date: May 14, 2025 A series of 2-(aryl)benzoimidazothiazole-7-sulfonamide derivatives were synthesized and evaluated for their antitubercular and antibacterial activities, molecular docking, and DFT studies. The compounds were synthesized through ... Read more